Anavex Life Sciences Corp (AVXL)

[Steady_T]

I can think of several reasons for choosing an ultra rare disease.

No SOC to compete with.

Lots of pressure from advocacy groups to get it approved if it works.

Good will in general for Anavex.

Small trial numbers so it should be a cheap trial to run.

If Rett trial is as good as we think, could be a one trial to an NDA.

Broadens the MOA to a general CNS drug by showing the disparate indications that it has efficacy upon.

Might obtain a high price for the drug to offset the low numbers of people being treated.